I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Case Report: Clinical benefit from multi-target tyrosine ki..:
Yu, Ling
;
Lin, Jietao
;
Li, Hanhan
...
Frontiers in Pharmacology. 14 (2023) - p. , 2023
Link:
https://doi.org/10.3389/fphar.2023.997760
RT Journal T1
Case Report: Clinical benefit from multi-target tyrosine kinase inhibitor and PARP inhibitor in a patient with cancer of unknown primary with BRCA1 large genomic rearrangement
UL https://suche.suub.uni-bremen.de/peid=cr-10.3389_fphar.2023.997760&Exemplar=1&LAN=DE A1 Yu, Ling A1 Lin, Jietao A1 Li, Hanhan A1 Sun, Lingling A1 Wang, Shubo A1 Chen, Yaoxu A1 Chen, Hanrui A1 Lin, Lizhu PB Frontiers Media SA YR 2023 SN 1663-9812 JF Frontiers in Pharmacology VO 14 LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.997760 DO https://doi.org/10.3389/fphar.2023.997760 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)